Exact Mass: 516.2934

Exact Mass Matches: 516.2934

Found 30 metabolites which its exact mass value is equals to given mass value 516.2934, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

L-Olivosyl-oleandolide

(3R,5S,6S,7R,8S,9R,12R,13R,14S,15R)-8-[(2R,4S,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-6,14-dihydroxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione

C26H44O10 (516.2934)


3-O-(alpha-L-olivosyl)oleandolide is a macrolide that is oleandolide having a 2,6-dideoxy-alpha-L-arabino-hexopyranosyl (alpha-L-olivosyl) residue attached at position 3. It has a role as a metabolite. It is a macrolide, a glycoside and a monosaccharide derivative. It is functionally related to an oleandolide. L-Olivosyl-oleandolide is a naturally occurring sesquiterpene lactone derivative that contains an olivosyl moiety, which is a specific type of ester derived from olivolic acid. The "L" in the name indicates that the olivosyl group is in the L-configuration, which refers to the spatial arrangement of atoms around the chiral center in the molecule. This compound is an example of a glycosylated sesquiterpene lactone, where the sesquiterpene lactone oleandolide is modified by the attachment of the olivosyl group. The presence of the olivosyl group can alter the biological properties of the parent compound, oleandolide, potentially affecting its pharmacological activities such as cytotoxicity, anti-inflammatory effects, and antimicrobial activity. L-Olivosyl-oleandolide can be found in certain plant species and may contribute to the plant's defense mechanisms against pathogens and herbivores. In its chemical structure, L-Olivosyl-oleandolide consists of a sesquiterpene lactone core with a lactone ring fused to a sesquiterpene framework, and it is appended with the L-olivosyl ester group, which adds complexity to its molecular structure and function. This compound is of interest in the fields of natural products chemistry and pharmacognosy for its potential therapeutic applications and as a subject of study for understanding the biosynthesis of such natural products.

   

Pseudomonic acid I

Pseudomonic acid I

C26H44O10 (516.2934)


   

Tricalysioside L

Tricalysioside L

C26H44O10 (516.2934)


   

Tricalysioside M

Tricalysioside M

C26H44O10 (516.2934)


   
   

6-O-Acetyl-2,3,4-tri-O-<(+)-3-methylvaleryl>-beta-D-glucose

6-O-Acetyl-2,3,4-tri-O-<(+)-3-methylvaleryl>-beta-D-glucose

C26H44O10 (516.2934)


   

Mupirocin Caclium Impurity A

Mupirocin Caclium Impurity A

C26H44O10 (516.2934)


   

(1beta,5beta,7alpha,8xi,9beta,10alpha,11alpha,14beta)-7,8,11,14-tetrahydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside B

(1beta,5beta,7alpha,8xi,9beta,10alpha,11alpha,14beta)-7,8,11,14-tetrahydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside B

C26H44O10 (516.2934)


   
   

2,6-Diacetyl-3,4-diisobutyryl-1-O-octylglucopyranoside

2,6-Diacetyl-3,4-diisobutyryl-1-O-octylglucopyranoside

C26H44O10 (516.2934)


   

2beta,15S,16,17,19-pentahydroxyisopimar-8(14)-ene 17-O-beta-D-glucopyranoside

2beta,15S,16,17,19-pentahydroxyisopimar-8(14)-ene 17-O-beta-D-glucopyranoside

C26H44O10 (516.2934)


   
   

Ophiopogonside A

Ophiopogonside A

C26H44O10 (516.2934)


   

9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid

9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid

C26H44O10 (516.2934)


   

3-O-(alpha-L-olivosyl)oleandolide

3-O-(alpha-L-olivosyl)oleandolide

C26H44O10 (516.2934)


A macrolide that is oleandolide having a 2,6-dideoxy-alpha-L-arabino-hexopyranosyl (alpha-L-olivosyl) residue attached at position 3.

   
   

ST 20:0;O5;Hex

ST 20:0;O5;Hex

C26H44O10 (516.2934)


   

2-(hydroxymethyl)-6-{[1-(hydroxymethyl)-1,4a-dimethyl-7-(1,2,3-trihydroxypropan-2-yl)-2,3,4,4b,5,6,7,8,10,10a-decahydrophenanthren-2-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[1-(hydroxymethyl)-1,4a-dimethyl-7-(1,2,3-trihydroxypropan-2-yl)-2,3,4,4b,5,6,7,8,10,10a-decahydrophenanthren-2-yl]oxy}oxane-3,4,5-triol

C26H44O10 (516.2934)


   

2,6-diacetyl-3,4-diisobutyryl-1-o-octylgluco-pyranoside

NA

C26H44O10 (516.2934)


{"Ingredient_id": "HBIN004873","Ingredient_name": "2,6-diacetyl-3,4-diisobutyryl-1-o-octylgluco-pyranoside","Alias": "NA","Ingredient_formula": "C26H44O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5331","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2s,4r,4ar,4br,5r,8ar,10r,10as)-2-ethenyl-2,4b,8,8-tetramethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1,4,10,10a-tetrol

(1r,2s,4r,4ar,4br,5r,8ar,10r,10as)-2-ethenyl-2,4b,8,8-tetramethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1,4,10,10a-tetrol

C26H44O10 (516.2934)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5r,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5r,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C26H44O10 (516.2934)


   

2-(hydroxymethyl)-6-{[6,14,15-trihydroxy-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methoxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[6,14,15-trihydroxy-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methoxy}oxane-3,4,5-triol

C26H44O10 (516.2934)


   

2-(hydroxymethyl)-6-({3-methyl-5-[4,6,7-trihydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl}oxy)oxane-3,4,5-triol

2-(hydroxymethyl)-6-({3-methyl-5-[4,6,7-trihydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl}oxy)oxane-3,4,5-triol

C26H44O10 (516.2934)


   

2-(hydroxymethyl)-6-{[6,14,15-trihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[6,14,15-trihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C26H44O10 (516.2934)


   

(2r,3r,4s,5s,6r)-2-{[(2e)-5-[(1s,4s,4ar,5s,6r,7r,8ar)-4,6,7-trihydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2e)-5-[(1s,4s,4ar,5s,6r,7r,8ar)-4,6,7-trihydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O10 (516.2934)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4ar,4bs,7s,10ar)-1-(hydroxymethyl)-1,4a-dimethyl-7-(1,2,3-trihydroxypropan-2-yl)-2,3,4,4b,5,6,7,8,10,10a-decahydrophenanthren-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4ar,4bs,7s,10ar)-1-(hydroxymethyl)-1,4a-dimethyl-7-(1,2,3-trihydroxypropan-2-yl)-2,3,4,4b,5,6,7,8,10,10a-decahydrophenanthren-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O10 (516.2934)


   

(2r,3r,4s,5r,6r)-5-(acetyloxy)-2-[(acetyloxy)methyl]-4-[(2-methylpropanoyl)oxy]-6-(octyloxy)oxan-3-yl 2-methylpropanoate

(2r,3r,4s,5r,6r)-5-(acetyloxy)-2-[(acetyloxy)methyl]-4-[(2-methylpropanoyl)oxy]-6-(octyloxy)oxan-3-yl 2-methylpropanoate

C26H44O10 (516.2934)


   

5-(acetyloxy)-2-[(acetyloxy)methyl]-4-[(2-methylpropanoyl)oxy]-6-(octyloxy)oxan-3-yl 2-methylpropanoate

5-(acetyloxy)-2-[(acetyloxy)methyl]-4-[(2-methylpropanoyl)oxy]-6-(octyloxy)oxan-3-yl 2-methylpropanoate

C26H44O10 (516.2934)


   

2-ethenyl-2,4b,8,8-tetramethyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1,4,10,10a-tetrol

2-ethenyl-2,4b,8,8-tetramethyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1,4,10,10a-tetrol

C26H44O10 (516.2934)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5r,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5r,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methoxy}oxane-3,4,5-triol

C26H44O10 (516.2934)